Navigation Links
Biosite's Triage Products Seized by Beijing Customs; Chinese Market Facing Shortage
Date:4/26/2010

SHANGHAI, April 26 /PRNewswire-Asia/ -- Biosite's Triage products imported by Inverness Medical Beijing Co., Ltd. in April 2010 have been seized by Beijing Customs for not complying with the applicable importation regulations. As a result, the Chinese market is facing a severe shortage.

According to Beijing Customs, the Inspection and Quarantine Bureau of Beijing Customs raised questions regarding the propriety of the importation documents submitted by Inverness Medical Beijing, and subsequently seized all products imported at issue. Beijing Customs did not provide a clear timetable regarding when it will release these products. This news caused renewed concerns in the Chinese market, as distributors and end-users worry that the disruption in the supply of Triage products will adversely affect their use in hospitals. Currently, there is not much inventory left in the market, and it is estimated that the existing inventory can only last about a week. Some hospitals have already run out of Biosite products. Once a hospital runs out of Biosite products, it will be forced to use alternative products from other manufacturers.

In 2009, the total sales of Biosite products distributed through Chinmax Medical Systems, Inc. reached US $20 million. In particular, the Triage BNP test product is the best selling product in the heart failure diagnostics market in China. The dispute with Chinmax and the customs seizure has opened the door to Biosite's competitors, e.g. Roche, Abbott, Bayer/Siemens, BioMeuriex etc.

Biosite Incorporated is a worldwide pioneer in cardiac biomarkers based in San Diego, California, USA. Biosite was acquired by Inverness Medical Innovations, Inc. (NYSE: IMA) in June 2007. Chinmax Medical Systems, Inc., a leading distributor of clinical diagnostics in China, has been distributing Biosite products since 1999. On January 28, 2010, Chinmax filed suit in Shanghai regional district court against Inverness Medical Beijing (IMB), the Chinese subsidiary of Inverness Medical Innovations, claiming IMB infringed on Chinmax's exclusive distribution rights in China.


'/>"/>
SOURCE Chinmax Medical Systems, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. T-System Provides Free Medical Documentation Templates and Bi-Lingual Triage Questionnaires for Haiti Relief Medical Personnel
2. Triage Wireless, Inc. Becomes Sotera Wireless, Inc.
3. Vermillion Files 510(k) Application With U.S. Food & Drug Administration for OVA1 Ovarian Tumor Triage Test
4. AspenBio Pharma Reports Strong Results with Appendicitis Triage Blood Test from Large Multiple Hospital Study
5. China Sky One Medical Prepares to Launch 13 New Products
6. China Biologic Products Schedules Conference Call to Discuss Fourth Quarter and Full Year 2009 Results
7. ATS Medical Receives Approval to Commercialize the ATS Simulus Annuloplasty Products in Canada
8. EndoChoice(R) Launches CEU Program on Proper Endoscope Reprocessing and a Line of Flexible Endoscope Reprocessing Products
9. Statement From Eli Lilly and Company Regarding Stolen Company Products From Enfield, Connecticut Distribution Operations
10. China Biologic Products to Present at the Rodman & Renshaw Annual China Investment Conference
11. Corgenix Medical Corp. Announces Launch of Products for Automated Systems
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/23/2016)... Research and Markets has announced the ... to 2022" report to their offering. ... patients with kidney failure, it replaces the function of kidneys ... blood and thus the treatment helps to keep the patient ... Increasing number of ESRD patients & substantial ...
(Date:6/23/2016)... June 23, 2016  In a startling report released today, ... residents by lacking a comprehensive, proven plan to eliminate prescription opioid ... ranking of how states are tackling the worst drug crisis in ... states – Kentucky , New Mexico ... . Of the 28 failing states, three – ...
(Date:6/23/2016)... Capricor Therapeutics, Inc. ... company focused on the discovery, development and commercialization ... in its ongoing randomized HOPE-Duchenne clinical trial (Halt ... its 24-patient target. Capricor expects the trial to ... 2016, and to report top line data from ...
Breaking Medicine Technology:
(Date:6/25/2016)... ... ... First Choice Emergency Room , the largest network of independent freestanding ... of its new Mesquite-Samuell Farm facility. , “We are pleased to announce Dr. ... James M. Muzzarelli, Executive Medical Director of First Choice Emergency Room. , Dr. ...
(Date:6/25/2016)... ... June 25, 2016 , ... Dr. Calvin Johnson ... Recently, he has implemented orthobiologic procedures as a method for treating his patients. ... the first doctors to perform the treatment. Orthobiologics are substances that orthopaedic surgeons ...
(Date:6/25/2016)... Canada (PRWEB) , ... June 25, 2016 , ... Conventional ... pursuit of success. In terms of the latter, setting the bar too high can ... risk more than just slow progress toward their goal. , Research from ...
(Date:6/24/2016)... , ... June 24, 2016 , ... Those who have ... these feelings, many turn to unhealthy avenues, such as drug or alcohol abuse, as ... Michigan, has released tools for healthy coping following a traumatic event. , Trauma sufferers ...
(Date:6/24/2016)... ... 24, 2016 , ... Marcy was in a crisis. Her son James, eight, was out of ... verbally and physically. , “When something upset him, he couldn’t control his emotions,” remembers Marcy. ... throw rocks at my other children and say he was going to kill them. ...
Breaking Medicine News(10 mins):